---
title: Coin-sized device effectively treats basal cell carcinoma at home
---

Plus, plain language summaries of the CROWN and ENLIVEN trials

| View in browser Weekly newsletter  7 October 2021 Highlights Plain language summary of the ENLIVEN study: pexidartinib for tenosynovial giant cell tumor Top 3 drug approvals in oncology: September 2021 Panel discussion: setting the roadmap for optimizing cancer clinical trials   Latest News Coin-sized photodynamic therapy device effectively treats basal cell carcinoma at home CHRYSALIS-2: positive results demonstrate efficacy of amivantamab, lazertinib and chemotherapy combo ESMO21: Results of first randomized trial, FIRSTMAPPP, for rare neuroendocrine tumor   Journal article of the week Plain language summary of the CROWN study: lorlatinib with crizotinib for untreated NSCLC   Kind regards, Jade Parker Senior Editor, Oncology Central Future Medicine Ltd, Unitec House, 2 Albert Place, Finchley Central, London N3 1QB, UK, +44 (0) 20 8371 6090 Manage preferences Unsubscribe Privacy Policy Terms & Conditions |
| --- |